The NRT smoking cessation aids category in the Philippines is seeing relatively low value growth in 2025 as it competes for the same quitting occasions with an everexpanding vape ecosystem. Since the Vaporized Nicotine and NonNicotine Products Regulation Act (RA 11900) came into force (and was strengthened via implementing rules in late 2024), heated tobacco and evapor products have been more visible, regulated and, crucially, easier to discover across specialty shops and online. This keeps a la

Value sales of NRT smoking cessation aids are rising marginally in New Zealand in 2025, driven by increased awareness of the dangers of smoking and the success of years of progressive tobacco control policies leading to a marked decline in smoking prevalence overall. According to the Ministry of Health (Manatu Hauora), tobacco causes between 4,500 and 5,000 deaths every year. As a result, since 2011, New Zealand has been pursuing an ambitious goal with the Smokefree Aotearoa 2025 plan. The plan

Value sales of NRT smoking cessation aids are increasing in Singapore 2025, helped by persistent government action to reduce smoking and vaping prevalence. The Singapore government is maintaining a strong focus on tobacco-control measures, guided by the ACE Clinical Guideline (ACG), which highlights the importance of sustained support for smokers seeking to quit.

In 2025, NRT smoking cessation aids in Italy recorded a further decline in both volume and value terms. Among the main reasons for this decline are growing competition and cannibalisation by new-generation tobacco substitutes, such as electronic cigarettes and heated tobacco products. These products have quickly gained consumer favour and market share thanks to strong technological innovation, a wide range of flavours and greater personalisation of the consumer experience. In addition, more and

NRT smoking cessation aids in Spain is projected to see a further drop in retail volume and current value sales across the board over 2025, in line with overall decline in smoking prevalence among the adult population in the country. Fewer smokers means a smaller audience for NRT smoking cessation aids. The event of the COVID-19 pandemic also contributed to this development, due to the direct effects of smoking and upper respiratory tract disorders, along with the overarching health and wellbein

Current value sales of NRT smoking cessation aids rose moderately in 2025, driven by several notable factors. Government-led health initiatives, such as the HSE’s “Quit” programme, played a significant role by offering complementary support and actively promoting NRT products to the public. Tobacco became increasingly expensive due to higher excise duties, which made quitting smoking a more appealing financial decision. Stricter regulations extended smoke-free zones across public spaces and work

NRT smoking cessation aids in South Africa is projected to see moderate retail volume and strong retail current value growth over 2025, albeit at slower rates than in 2024. The category faces significant challenges, primarily due to the limited awareness and accessibility of these products among local consumers. Although the adult smoking rate in the country has been trending downwards, due largely to pricing and the growing health and wellness trend, some consumers are opting for alternative me

Sales of NRT smoking cessation aids have seen strong growth in current value terms in 2025. This growth has been supported by public health policies and rising demand for healthier alternatives. Another key factor has been the ban on closed-system e-vapour products which came into force in France in February 2025. The ban on disposable single-use closed system products was due to concerns around the appeal these products have with teenagers due to their use of bright colours and flavours. booste

Demand for NRT smoking cessation aids in Thailand continues to rise, with the country’s high smoking penetration rate (driven mainly by the adult male population) offering a wide target audience for brands to focus on. The Thai government also remains steadfast in its efforts to promote smoking cessation among its citizens, driven by the goal of reducing the social costs associated with a smoking population. One initiative has involved a collaboration between the Thailand National Quitline and t

Value sales of NRT smoking cessation aids are seeing lowish growth in Hong Kong in 2025. Hong Kong has made significant progress in tobacco control, achieving a historic low in adult smoking prevalence. This reflects the effectiveness of sustained public health initiatives, which have included comprehensive education campaigns, stricter regulations on tobacco advertising, and increased taxation on tobacco products.

Despite continued government-led anti-smoking campaigns and a gradual decline in smoking prevalence, sales of nicotine replacement therapy (NRT) products remain in deep decline in Saudi Arabia in 2025. While the percentage of smokers is slowly falling, this has not translated into higher demand for cessation aids. Most smokers who attempt to quit continue to rely on unassisted methods; among some segments of the population, awareness of NRT options remains limited and consumers favour willpower-

NRT smoking cessation aids is expected to register minimal current value and volume growth in Portugal in 2025. In October 2024, two new brands, Cuitvar and Xistab from Champamix, with both containing the active ingredient varenicline and containing no nicotine were approved for 37% reimbursement from public health, leaving the cost to consumers at about €26 per month. This represents significant value comparted to NRT offerings and as a result is expected to have a dampening effect on value sal

Value sales of NRT smoking cessation aids in Greece increased slightly in 2025. Despite increased advertising investment by market leader Nicorette, the sole OTC brand in the category, penetration of NRT remains limited. While consumer awareness is gradually improving, the majority of smokers continue to favour alternative methods for quitting, with NRT appealing only to a relatively small consumer base.

Sales of NRT smoking cessations aids have declined in both value and volume terms in 2025 as smoking prevalence continues to decline in Denmark. Cigarette sales in Denmark have been in steady decline since 2017 and as the number of smokers decline the number of potential consumers of NRT products is also declining. Additionally, many smokers are turning to alternative methods of quitting, from switching to e-vapour products, to hypnosis, to simply going cold turkey, all of which has placed furth

Value sales of NRT smoking cessation aids are increasing in Malaysia 2025, but growth has slowed substantially compared to the previous year. Several factors are limiting demand, including ongoing economic pressures from the rising cost of living and the growing popularity of e-cigarettes and vaping. Both trends are reducing reliance on NRT products.

NRT smoking cessation aids is seeing a rebound in 2025, with value sales increasing after a sharp decline in 2024. The previous year’s contraction was mainly the result of health insurance funds being withdrawn for these products, which discouraged uptake. The limited presence of just two active players also restricted growth. In 2025, however, stronger visibility in pharmacies and promotional investments are paying off, with demand rising again, particularly for NRT gum.

NRT smoking cessation aids is recording declines in both value and volume sales in Sweden in 2025, reflecting the ongoing reduction in smoking prevalence in Sweden. As cigarette sales continue to contract and the overall number of smokers declines, the consumer base for NRT products is also shrinking.

Value sales of NRT smoking cessation aids increased in Taiwan in 2025, reflecting a continued decline in smoking prevalence and strong support for public health policies. According to the latest survey conducted by the National Health Administration, the smoking rate among individuals aged 18 and over fell to 12.8% in 2024, down from 14% in 2022. This steady decline is being reinforced by a series of government initiatives aimed at limiting public smoking, including the reduction of designated s

NRT smoking cessation aids in Romania is set to record positive growth in current value terms in 2025, largely driven by rising prices. The category, however, continues to face considerable challenges, particularly due to persistent inflation, which is curbing household spending on non-essential products. Nevertheless, awareness of smoking-related health risks increasing. Cigarette consumption is being discouraged by multiple factors, including public health campaigns, higher excise taxes on tob

NRT smoking cessation aids is poised for marginal value growth in 2025, driven by Israel’s incremental increase in VAT at the start of the year. Despite the small rise in value sales, consumer demand is in decline as more people returned to smoking as a way to reduce the stress and uncertainty caused by the ongoing Israel-Hams war and regional hotspots.

NRT smoking cessation aids is not a notably significant category in Peru. Indeed, such products are niche and are not widely available having failed to attract consumer attention. Smokers prefer to opt for natural and more economical remedies when looking to quit smoking. NRT patches is the only product available in NRT smoking cessation aids in Peru, but sales remain negligible with these products seen as being very expensive by the small number of local consumers who are even aware of them, wi

Value sales of nicotine replacement therapy (NRT) smoking cessation aids increased in Hungary in 2025. Consumers increasingly recognise smoking as a harmful habit with serious health consequences, influenced by growing government-led campaigns that highlighted the negative effects of tobacco use. Rising cigarette prices further supported demand, as smokers are incentivised to redirect spending towards more essential goods and alternatives to smoking.

There is a growing focus on reducing smoking prevalence in Poland, which has proven effective with the percentage of adults who smoke continuing on downward trajectory in 2025. This has had a mixed impact on demand for NRT smoking cessation aids. On one hand, as more consumers look to quit this is boosting sales. However, on the other hand, as the smoking population declines so does the potential target audience for NRT smoking cessation aids.

Current value sales of NRT smoking cessation aids rose substantially in Turkey in 2025 albeit at a slower rate than in the previous year of the review period as inflation remained significantly above the central bank's year-end target.